Affiliation:
1. Center for Preventive Doping Research ‐ Institute of Biochemistry German Sport University Cologne Cologne Germany
2. European Monitoring Center for Emerging Doping Agents Cologne Germany
3. Swiss Laboratory for Doping Analyses University Center of Legal Medicine, Genève and Lausanne, Centre Hospitalier Universitaire Vaudois and University of Lausanne Epalinges Switzerland
Abstract
AbstractIn this 16th edition of the annual banned‐substance review on analytical approaches in human sports drug testing, literature on recent developments in this particular section of global anti‐doping efforts that was published between October 2022 and September 2023 is summarized and discussed. Most recent additions to the continuously growing portfolio of doping control analytical approaches and investigations into analytical challenges in the context of adverse analytical findings are presented, taking into account existing as well as emerging challenges in anti‐doping, with specific focus on substances and methods of doping recognized in the World Anti‐Doping Agency's 2023 Prohibited List. As in previous years, focus is put particularly on new or enhanced analytical options in human doping controls, appreciating the exigence and core mission of anti‐doping and, equally, the conflict arising from the opposingly trending extent of the athlete's exposome and the sensitivity of instruments nowadays commonly available in anti‐doping laboratories.
Subject
Spectroscopy,Pharmaceutical Science,Environmental Chemistry,Analytical Chemistry